The nutritional products division of the company announced that through the use of nutrigenomics, scientists have identified a number of genes associating vitamin E with protection against Alzheimer’s disease. Alzheimer’s disease is a growing public health concern as the number of people suffering from it is increasing rapidly. Estimates suggest that around 4.5 million people in the US alone live with the disease for which, at present, there is no cure or prevention. A number of epidemiologic studies have suggested the benefits of vitamin E in reducing the risk of Alzheimer’s disease, with one clinical trial showing a significant delay in the onset of the disease in a vitamin E supplemented group. However, as DSM pointed out, the underlying molecular mechanisms remain poorly understood. The researchers therefore concluded that vitamin E appeared to have a protective role in the prevention/onset of age-related neurologic diseases, in particular Alzheimer’s.